Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients

Abstract The composition of the gut microbiome of patients with advanced non-small cell lung cancer is currently considered a factor influencing the effectiveness of treatment with immune checkpoint inhibitors. We aimed to evaluate the baseline gut microbiome composition in patients before receiving...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, Arkadiusz Bomba, Katarzyna Bielińska, Paweł Krawczyk, Izabela Chmielewska, Małgorzata Frąk, Michał Szczyrek, Anna Rolska-Kopińska, Tomasz Jankowski, Robert Kieszko, Janusz Milanowski
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Subjects:	Microbiome NSCLC Immunotherapy 16S rRNA Immunotherapy efficacy
Online Access:	https://doi.org/10.1038/s41598-025-89406-1